Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
438.34
-9.87 (-2.20%)
At close: May 15, 2026, 4:00 PM EDT
437.98
-0.36 (-0.08%)
Pre-market: May 18, 2026, 9:12 AM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $11.01B in the quarter ending March 28, 2026, with 6.18% growth. This brings the company's revenue in the last twelve months to $45.20B, up 5.36% year-over-year. In the year 2025, Thermo Fisher had annual revenue of $44.56B with 3.91% growth.
Revenue (ttm)
$45.20B
Revenue Growth
+5.36%
P/S Ratio
3.60
Revenue / Employee
$361,576
Employees
125,000
Market Cap
162.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.56B | 1.68B | 3.91% |
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
| Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
| Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
| Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
| Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
| Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
| Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
| Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
| Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
| Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
| Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
| Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
| Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
| Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
| Dec 31, 2005 | 2.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Danaher | 24.78B |
| IQVIA Holdings | 16.63B |
| Labcorp Holdings | 14.14B |
| Quest Diagnostics | 11.28B |
| Agilent Technologies | 7.07B |
| IDEXX Laboratories | 4.45B |
| Illumina | 4.39B |
| Mettler-Toledo International | 4.09B |
TMO News
- 49 minutes ago - Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden - Business Wire
- 2 hours ago - Amazon among seven added to Jefferies’ Franchise Picks list - TheFly
- 3 days ago - Thermo Fisher resumed with a Sector Perform at RBC Capital - TheFly
- 4 days ago - Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC - TheFly
- 7 days ago - Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle - Business Wire
- 12 days ago - Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials - Business Wire
- 14 days ago - Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing - Business Wire
- 20 days ago - Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies - Business Wire